The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study

<b>Background: </b>Preeclampsia and its association with thrombophilia remain controversial, due to inconsistent results in different studies, which include different ethnic groups, selection criteria, and patient numbers. The aim of this study was to determine the relationship between t...

Full description

Bibliographic Details
Main Authors: Yalinkaya Ahmet, Erdemoglu Mahmut, Akdeniz Nurten, Kale Ahmet, Kale Ebru
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2006-01-01
Series:Annals of Saudi Medicine
Online Access:http://www.saudiannals.net/article.asp?issn=0256-4947;year=2006;volume=26;issue=2;spage=105;epage=109;aulast=Yalinkaya
_version_ 1819157640023900160
author Yalinkaya Ahmet
Erdemoglu Mahmut
Akdeniz Nurten
Kale Ahmet
Kale Ebru
author_facet Yalinkaya Ahmet
Erdemoglu Mahmut
Akdeniz Nurten
Kale Ahmet
Kale Ebru
author_sort Yalinkaya Ahmet
collection DOAJ
description <b>Background: </b>Preeclampsia and its association with thrombophilia remain controversial, due to inconsistent results in different studies, which include different ethnic groups, selection criteria, and patient numbers. The aim of this study was to determine the relationship between thrombophilia and preeclamptic patients in our region. <b>Methods: </b>In a prospective case-control study, we compared 100 consecutive women with preeclampsia and eclampsia (group 1) with 100 normal pregnant women (group 2). All women were tested two months after delivery for mutations of factor V Leiden, methylenetetrahydrofolate reductase (MTHFR), and prothrombin gene mutation as well as for deficiencies of protein C, protein S, and antithrombin III. <b>Results: </b>A thrombophilic mutation was found in 42 (42&#x0025;) and 28 (28&#x0025;) women in group 1 and group 2, respectively (<i>P</i>=0.27, OR 1.5, 95&#x0025;CI 1.0- 2.2). The incidence of Factor V Leiden mutation (heterozygous), prothrombin mutation (heterozygous), prothrombin mutation (homozygous), MTHFR mutation (homozygous) was not statistically significant in group 1 compared with group 2 (<i>P</i>>0.05). Also, deficiencies of protein S, protein C, and antithrombin III were not statistically significant in group 1 compared with group 2 (<i>P </i>>0.05). <b>Conclusion: </b>There was no difference in thrombophilic mutations between preeclamptic patients and normal pregnant women in our region. Therefore, we suggest that preeclamptic patients should not be tested for thrombophilia.
first_indexed 2024-12-22T16:11:58Z
format Article
id doaj.art-f21da3a560dd4bd09ef18d23485fc588
institution Directory Open Access Journal
issn 0256-4947
0975-4466
language English
last_indexed 2024-12-22T16:11:58Z
publishDate 2006-01-01
publisher King Faisal Specialist Hospital and Research Centre
record_format Article
series Annals of Saudi Medicine
spelling doaj.art-f21da3a560dd4bd09ef18d23485fc5882022-12-21T18:20:28ZengKing Faisal Specialist Hospital and Research CentreAnnals of Saudi Medicine0256-49470975-44662006-01-01262105109The relationship between thrombophilic mutations and preeclampsia : A prospective case-control studyYalinkaya AhmetErdemoglu MahmutAkdeniz NurtenKale AhmetKale Ebru<b>Background: </b>Preeclampsia and its association with thrombophilia remain controversial, due to inconsistent results in different studies, which include different ethnic groups, selection criteria, and patient numbers. The aim of this study was to determine the relationship between thrombophilia and preeclamptic patients in our region. <b>Methods: </b>In a prospective case-control study, we compared 100 consecutive women with preeclampsia and eclampsia (group 1) with 100 normal pregnant women (group 2). All women were tested two months after delivery for mutations of factor V Leiden, methylenetetrahydrofolate reductase (MTHFR), and prothrombin gene mutation as well as for deficiencies of protein C, protein S, and antithrombin III. <b>Results: </b>A thrombophilic mutation was found in 42 (42&#x0025;) and 28 (28&#x0025;) women in group 1 and group 2, respectively (<i>P</i>=0.27, OR 1.5, 95&#x0025;CI 1.0- 2.2). The incidence of Factor V Leiden mutation (heterozygous), prothrombin mutation (heterozygous), prothrombin mutation (homozygous), MTHFR mutation (homozygous) was not statistically significant in group 1 compared with group 2 (<i>P</i>>0.05). Also, deficiencies of protein S, protein C, and antithrombin III were not statistically significant in group 1 compared with group 2 (<i>P </i>>0.05). <b>Conclusion: </b>There was no difference in thrombophilic mutations between preeclamptic patients and normal pregnant women in our region. Therefore, we suggest that preeclamptic patients should not be tested for thrombophilia.http://www.saudiannals.net/article.asp?issn=0256-4947;year=2006;volume=26;issue=2;spage=105;epage=109;aulast=Yalinkaya
spellingShingle Yalinkaya Ahmet
Erdemoglu Mahmut
Akdeniz Nurten
Kale Ahmet
Kale Ebru
The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
Annals of Saudi Medicine
title The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
title_full The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
title_fullStr The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
title_full_unstemmed The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
title_short The relationship between thrombophilic mutations and preeclampsia : A prospective case-control study
title_sort relationship between thrombophilic mutations and preeclampsia a prospective case control study
url http://www.saudiannals.net/article.asp?issn=0256-4947;year=2006;volume=26;issue=2;spage=105;epage=109;aulast=Yalinkaya
work_keys_str_mv AT yalinkayaahmet therelationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT erdemoglumahmut therelationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT akdeniznurten therelationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT kaleahmet therelationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT kaleebru therelationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT yalinkayaahmet relationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT erdemoglumahmut relationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT akdeniznurten relationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT kaleahmet relationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy
AT kaleebru relationshipbetweenthrombophilicmutationsandpreeclampsiaaprospectivecasecontrolstudy